Abstract
The development of methods for efficiently introducing foreign genes into living cells provides novel tools to investigate intracellular processes at the molecular level. In addition, the development of suitable delivery vehicles for in vivo gene transfer is a prerequisite for clinical application of therapeutic genes. This review will summarize the current status of the development of both viral as well as non-viral vectors for gene therapy. In addition, we also discuss novel gene-delivery vehicles based on viral envelopes containing fusogenic spike proteins originated from different myxoviruses. These recombinant viral envelopes or virosomes could be viewed as hybrid vectors combining both viral and non-viral strategies, and are well suited for a wider application in therapeutic gene and drug delivery.
Keywords: fusogenic viral envelopes, gene transfer, myxoviruses, non-viral gene transfer, liposome-Mediated gene transfer, virosomes
Current Genomics
Title: Fusogenic Viral Envelopes as Potent Vehicles for Gene Transfer
Volume: 2 Issue: 3
Author(s): Evgeni G. Ponimaskin and Michael f.g. Schmidt
Affiliation:
Keywords: fusogenic viral envelopes, gene transfer, myxoviruses, non-viral gene transfer, liposome-Mediated gene transfer, virosomes
Abstract: The development of methods for efficiently introducing foreign genes into living cells provides novel tools to investigate intracellular processes at the molecular level. In addition, the development of suitable delivery vehicles for in vivo gene transfer is a prerequisite for clinical application of therapeutic genes. This review will summarize the current status of the development of both viral as well as non-viral vectors for gene therapy. In addition, we also discuss novel gene-delivery vehicles based on viral envelopes containing fusogenic spike proteins originated from different myxoviruses. These recombinant viral envelopes or virosomes could be viewed as hybrid vectors combining both viral and non-viral strategies, and are well suited for a wider application in therapeutic gene and drug delivery.
Export Options
About this article
Cite this article as:
Ponimaskin G. Evgeni and Schmidt f.g. Michael, Fusogenic Viral Envelopes as Potent Vehicles for Gene Transfer, Current Genomics 2001; 2 (3) . https://dx.doi.org/10.2174/1389202013350814
DOI https://dx.doi.org/10.2174/1389202013350814 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Eicosanoids in Prevention and Management of Diseases
Current Molecular Medicine New Patents on Topical Anesthetics
Recent Patents on Inflammation & Allergy Drug Discovery Metformin in the Treatment of Polycystic Ovary Syndrome
Current Pharmaceutical Design The Role of Vascular Cell Senescence in Atherosclerosis: Antisenescence as a Novel Therapeutic Strategy for Vascular Aging
Current Vascular Pharmacology Mediterranean Diet and Risk of Dementia
Current Alzheimer Research Calcific Aortic Valve Disease and Hypertension
Current Hypertension Reviews The Metabolic Syndrome and the Relevance of Nutrients for its Onset
Recent Patents on Biotechnology Peroxynitrite-Driven Mechanisms in Diabetes and Insulin Resistance – the Latest Advances
Current Medicinal Chemistry Abstracts from Speakers
Cardiovascular & Hematological Disorders-Drug Targets Vessel Graft Atherosclerosis in Murine Models
Current Drug Targets Current Evidence and Future Perspectives on Anti-platelet and Statin Pharmacotherapy for Patients with Symptomatic Peripheral Arterial Disease
Current Vascular Pharmacology Genetics of Atherosclerosis in Murine Models
Current Drug Targets Methodologic Issues in the Validation of Putative Biomarkers and Surrogate Endpoints in Treatment Evaluation for Systemic Lupus Erythematosus
Endocrine, Metabolic & Immune Disorders - Drug Targets Paracrine Provision of Lipids in the Immune System
Current Immunology Reviews (Discontinued) Addressing Alzheimer’s Disease and Cognitive Loss through Autophagy
Current Neurovascular Research Virtual Screening Against Obesity
Current Medicinal Chemistry Glucocorticoids in Pregnancy
Current Pharmaceutical Biotechnology Phenomics of Vascular Disease: The Systematic Approach to the Combination Therapy
Current Vascular Pharmacology Restless Leg Syndrome in Patients with Liver Cirrhosis! Its Frequency, Severity, and Correlation
CNS & Neurological Disorders - Drug Targets NADPH Oxidase and Neurodegeneration
Current Neuropharmacology